US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Clinical Trial Market Research Reports & Industry Analysis

RSS Feeds

Clinical Trial Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Anti GM-CSF Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti GM-CSF Antibody. This report provides information on the therapeutic development based on the Anti GM-CSF Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Anti-CD152 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD152 Antibody. This report provides information on the therapeutic development based on the Anti-CD152 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD19 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD19 Antibody. This report provides information on the therapeutic development based on the Anti-CD19 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD28 Antibody. This report provides information on the therapeutic development based on the Anti-CD28 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD30 Antibody. This report provides information on the therapeutic development based on the Anti-CD30 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD33 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD33 Antibody. This report provides information on the therapeutic development based on the Anti-CD33 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD37 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD37 Antibody. This report provides information on the therapeutic development based on the Anti-CD37 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD70 Antibody. This report provides information on the therapeutic development based on the Anti-CD70 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-Mucin 1 (MUC1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... to establish the understanding for all the pipeline drugs that fall under Anti-Mucin 1 (MUC1) Antibody. This report provides information on the therapeutic development based on the Anti-Mucin 1 (MUC1) Antibody dealing with mechanism of ...  |  read more...
USD 1,250
Antithrombin Activators -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Antithrombin Activators. This report provides information on the therapeutic development based on the Antithrombin Activators dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Apoptosis Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Apoptosis Inhibitors. This report provides information on the therapeutic development based on the Apoptosis Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Arginine Depletors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Arginine Depletors. This report provides information on the therapeutic development based on the Arginine Depletors dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under ATP Binding Cassette ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... to establish the understanding for all the pipeline drugs that fall under Aurora A Kinase Inhibitors. This report provides information on the therapeutic development based on the Aurora A Kinase Inhibitors dealing with mechanism of ...  |  read more...
USD 1,250
Aurora B Kinase Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... to establish the understanding for all the pipeline drugs that fall under Aurora B Kinase Inhibitors. This report provides information on the therapeutic development based on the Aurora B Kinase Inhibitors dealing with mechanism of ...  |  read more...
USD 1,250
Aurora Kinase Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Aurora Kinase Inhibitors. This report provides information on the therapeutic development based on the Aurora Kinase Inhibitors dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Bacterial Efflux Pump Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... to establish the understanding for all the pipeline drugs that fall under Bacterial Efflux Pump Inhibitors. This report provides information on the therapeutic development based on the Bacterial Efflux Pump Inhibitors dealing with mechanism of ...  |  read more...
USD 1,250
B-Cell Activating Factor (BAFF) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... report is to establish the understanding for all the pipeline drugs that fall under B-Cell Activating Factor (BAFF) Inhibitors. This report provides information on the therapeutic development based on the B-Cell Activating Factor (BAFF) Inhibitors ...  |  read more...
USD 1,250
Beta Receptor Agonists -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Beta Receptor Agonists. This report provides information on the therapeutic development based on the Beta Receptor Agonists dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Beta Secretase inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Beta Secretase inhibitors. This report provides information on the therapeutic development based on the Beta Secretase inhibitors dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Beta Selective Thyroid Hormone Receptor Agonists -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... of the report is to establish the understanding for all the pipeline drugs that fall under Beta Selective Thyroid Hormone Receptor Agonists. This report provides information on the therapeutic development based on the Beta Selective ...  |  read more...
USD 1,250
Beta-1 Receptors Antagonists -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Beta-1 Receptors Antagonists. This report provides information on the therapeutic development based on the Beta-1 Receptors Antagonists dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Beta-1 Receptors Agonists -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Beta-1 Receptors Agonists. This report provides information on the therapeutic development based on the Beta-1 Receptors Agonists dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Viral RNA Polymerase Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... to establish the understanding for all the pipeline drugs that fall under Viral RNA Polymerase Inhibitors. This report provides information on the therapeutic development based on the Viral RNA Polymerase Inhibitors dealing with mechanism of ...  |  read more...
USD 1,250
Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... report is to establish the understanding for all the pipeline drugs that fall under Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers. This report provides information on the therapeutic development based on the Voltage-Dependent Calcium Channel Alpha-2/Delta Blockers ...  |  read more...
USD 1,250
6  7  8  9    11    13  14  15